Search Results 181-190 of 16672 for linagliptin

1. Emtricitabine, rilpivirine, and tenofovir alafenamide (oral route) - Side effects & dosage - Mayo Clinic

   HIV is the virus that causes acquired immune deficiency syndrome (AIDS). This medicine is usually given to patients who have not received any HIV treatment in ...

2. A Study to Assess Metformin Hydrochloride in Patients With Atypical Hyperplasia or In Situ Breast Cancer to Placebo in Decreasing Atypical Cells in Patients With Atypical Hyperplasia or in Situ Breast Cancer - Mayo Clinic

   Note: The standard drug used for the "breast cancer prevention" is tamoxifen. If the patient is eligible to take tamoxifen, he/she must be offered tamoxifen ...

3. Endocrinology - Clinical trials

   The purpose of this study is to establish incidence and prevalence of Impulse Control Disorders (ICDs) in patients with prolactinomas treated with dopamine ...

4. Testing The Addition Of Abemaciclib To Olaparib For Women With Recurrent Ovarian Cancer - Mayo Clinic

   Blocking PARP may help keep tumor cells from repairing their damaged DNA, causing them to die. PARP inhibitors are a type of targeted therapy. Adding ...

5. Tolvaptan (oral route) - Side effects & dosage - Mayo Clinic

   Tolvaptan is also used to slow kidney function decline in adults who are at risk of rapidly progressing autosomal dominant polycystic kidney disease (ADPKD).

6. Retifanlimab-dlwr (intravenous route) - Side effects & uses - Mayo Clinic

   Retifanlimab-dlwr injection is used in combination with other cancer medicines (eg, carboplatin, paclitaxel) as first-line treatment for a type of anal cancer ...

7. A Study Of TRX319 In Subjects With Primary Or Secondary Progressive Multiple Sclerosis - Mayo Clinic

   Patients with progressive forms of multiple sclerosis (MS) have limited. therapeutic options and require new, effective treatments. Ocrelizumab, an.

8. Tislelizumab-jsgr (intravenous route) - Side effects & uses - Mayo Clinic

   Your doctor will test for the presence of this tumor. This medicine is also used alone to treat ESCC that has spread of cannot be removed by surgery in patients ...

9. Glatiramer (subcutaneous route) - Side effects & dosage - Mayo Clinic

   Glatiramer injection is used to treat relapsing-forms of multiple sclerosis (MS), including clinically isolated syndrome, relapsing-remitting disease, and ...

10. Targeted Drug Therapy Clinical Trials - Mayo Clinic Research

    Among persons with Immunoglobulin G subclass 4 Related Disease (IgG4)-related disease who have persistent or recurrent disease despite standard therapies, does ...